---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-090121"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:39:04.957253+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Incannex appoints Dr. Luigi Barbato as CMO; base salary $375K, RSU grant of 100,476 shares vesting over 3 years

## Summary
- Dr. Barbato appointed Chief Medical Officer effective October 21, 2024; reports to CEO Joel Latham.
- Base salary of $375,000 with target annual incentive up to 20% of base salary.
- Granted 100,476 restricted stock units (approx. $200K / 5-day VWAP) vesting in 3 equal annual installments.
- Most recently Global Medical Lead at Jazz Pharmaceuticals; prior roles at AbbVie, Biogen, Novartis.

## SEC filing metadata
- accession: 0001213900-24-090121
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/0001213900-24-090121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/ea0218506-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-090121
- JSON: https://secwatch.observer/filing/0001213900-24-090121.json
- Plain text: https://secwatch.observer/filing/0001213900-24-090121.txt

## Key facts
- Executive change
  Luigi M. Barbato, M.D. was appointed as Chief Medical Officer at Incannex Healthcare Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Effective October 21, 2024 (the “Effective Date”), Incannex Healthcare Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Luigi M. Barbato, M.D., to serve as the Company’s Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/0001213900-24-090121-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.